Titan Securities Reports Mixed Q3FY26 Results with Standalone Profit Decline
Titan Securities Limited reported mixed Q3FY26 results with standalone net profit declining 46.93% to ₹37.88 lakhs from ₹71.37 lakhs in Q3FY25. Revenue from operations dropped significantly to ₹101.25 lakhs from ₹334.90 lakhs year-on-year. However, consolidated performance remained strong with net profit rising 44.37% to ₹367.18 lakhs, primarily driven by ₹329.30 lakhs contribution from associate companies. The Board approved these results on February 12, 2026.
*this image is generated using AI for illustrative purposes only.
Titan Securities Limited announced its unaudited financial results for the third quarter ended December 31, 2025, showing mixed performance across standalone and consolidated operations. The Board of Directors approved these results at their meeting held on February 12, 2026.
Standalone Financial Performance
The company's standalone operations faced challenges during Q3FY26, with net profit declining significantly compared to the previous year. Revenue from operations also contracted substantially during the quarter.
| Metric | Q3FY26 | Q3FY25 | Change (%) |
|---|---|---|---|
| Total Revenue from Operations | ₹101.25 lakhs | ₹334.90 lakhs | -69.77% |
| Net Profit After Tax | ₹37.88 lakhs | ₹71.37 lakhs | -46.93% |
| Basic EPS | ₹0.15 | ₹0.29 | -48.28% |
| Total Comprehensive Income | ₹65.79 lakhs | ₹164.42 lakhs | -59.98% |
The revenue decline was primarily attributed to lower sales of products (shares) which dropped to ₹44.85 lakhs from ₹273.81 lakhs in the corresponding quarter of the previous year. Dividend income remained relatively stable at ₹56.25 lakhs compared to ₹57.51 lakhs in Q3FY25.
Nine-Month Performance Analysis
For the nine-month period ended December 31, 2025, standalone performance showed continued pressure with total revenue from operations at ₹315.47 lakhs versus ₹778.97 lakhs in the corresponding period of FY25. Net profit for the nine-month period was ₹42.82 lakhs compared to ₹124.13 lakhs in the previous year, representing a decline of 65.51%.
Consolidated Results Show Strength
Despite standalone challenges, the consolidated results presented a robust picture, primarily driven by strong contributions from associate companies.
| Parameter | Q3FY26 | Q3FY25 | Change (%) |
|---|---|---|---|
| Consolidated Net Profit | ₹367.18 lakhs | ₹254.34 lakhs | +44.37% |
| Share in Profit of Associates | ₹329.30 lakhs | ₹182.97 lakhs | +79.97% |
| Consolidated EPS (Basic) | ₹1.47 | ₹1.02 | +44.12% |
| Total Comprehensive Income | ₹395.09 lakhs | ₹347.39 lakhs | +13.73% |
The consolidated results include contributions from associate companies Titan Biotech Limited and Peptech Biosciences Limited, which contributed ₹329.30 lakhs to the overall profit during Q3FY26.
Key Financial Highlights
The company maintained a stable capital structure with paid-up equity share capital remaining constant at ₹2,501.62 lakhs across all reporting periods. Other comprehensive income for the standalone entity was ₹27.91 lakhs in Q3FY26, primarily driven by re-measurement of equity instruments through other comprehensive income worth ₹36.54 lakhs.
Regulatory Compliance and Auditor Review
The financial results were reviewed by the Audit Committee and approved by the Board of Directors. The results have been subject to limited review by the statutory auditors Goyal Nagpal & Co., Chartered Accountants, in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has elected to exercise the option under section 115BAA of the Income Tax Act, 1961, for tax calculations.
Historical Stock Returns for Titan Securities
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.18% | +0.17% | -8.34% | +20.48% | -4.56% | +234.14% |
16
